Octreotide peptide
Octreotide is a real peptide or peptide-based medicine with regulated uses. Approval, formulation and indication depend on jurisdiction and product.
Use this Octreotide peptide record to separate compound identity, human evidence, regulatory status and COA quality. These are related but distinct questions.
What is Octreotide?
Octreotide is a synthetic analogue of the inhibitory peptide hormone somatostatin.
What does it do?
It activates selected somatostatin receptor subtypes and suppresses secretion of several hormones and gastrointestinal mediators.
Current use and status
Authorized products have molecule- and formulation-specific endocrine or tumour-related indications.
Approved prescription medicine for specific uses in at least one jurisdiction.
What the evidence does not prove
Receptor selectivity and depot formulation materially change effects; these medicines require diagnosis and monitoring.
Certificate quality signals
- Certificate lot and label lot should agree
- Measured values should name their analytical method
- The issuing laboratory and report identifier should be independently traceable
Octreotide peptide reference records
Use the public chemistry and regulatory or clinical-study records to confirm identity and current product status. A database listing is not a product endorsement.
Learn how to assess peptide evidence
Read the peptide safety, sourcing and certificate-verification guides before interpreting a seller or laboratory claim.
Browse peptide guides